Hong, United Kingdom

Paul Brian Little


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Paul Brian Little

Introduction

Paul Brian Little, a skilled inventor based in Hong, GB, has made significant contributions to the field of neuromuscular disorder treatments. With a strong focus on innovating compounds that can prevent and ameliorate these disorders, Little stands out as a dedicated figure in the pharmaceutical industry. His work is instrumental in addressing critical medical challenges, particularly concerning drug-induced neuromuscular blockade.

Latest Patents

Paul Brian Little holds one notable patent titled "Compounds for the treatment of neuromuscular disorders." This patent encompasses innovative compounds designed to treat, ameliorate, and prevent conditions related to neuromuscular disorders. Specifically, the compounds aim to inhibit the CIC-1 ion channel, showcasing the potential to reverse adverse effects associated with neuromuscular blockade. Among the compounds included in his patent are phenoxy propanoic acid, phenoxy propanoate, and phenoxy butanoate, indicating a focused approach to solving complex medical issues.

Career Highlights

His career at NMD Pharma A/S marks a significant chapter in Little's professional journey. His role at this dynamic company allows him to collaborate with fellow innovators and scientists dedicated to advancing pharmaceutical sciences. Little's expertise in neuromuscular treatments highlights his dedication to improving patient outcomes and contributing to medical advancements.

Collaborations

Throughout his career, Paul Brian Little has worked alongside esteemed colleagues such as Lars J. S. Knutsen and Thomas Holm Pedersen. These collaborations foster a rich environment of shared knowledge and innovation, further propelling research efforts at NMD Pharma A/S. Together, they explore new frontiers in medical science, combining their talents to enhance treatment strategies for patients suffering from neuromuscular disorders.

Conclusion

In summary, Paul Brian Little represents a beacon of innovation in the pharmaceutical industry. With a focused approach to neuromuscular disorders and a collaborative spirit, his contributions pave the way for future advancements in treatment options. Through his singular patent and ongoing collaborations, Little continues to impact the lives of many, showcasing the importance of dedicated research and innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…